BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1637339)

  • 1. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
    Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.
    Schnabel D; Schröder M; Fürst W; Klein A; Hurwitz R; Zenk T; Weber J; Harzer K; Paton BC; Poulos A
    J Biol Chem; 1992 Feb; 267(5):3312-5. PubMed ID: 1371116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
    Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
    Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
    Schmid B; Paton BC; Sandhoff K; Harzer K
    Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence that human lysosomal sialidase is not derived from prosaposin. Prosaposin biosynthesis and ganglioside sialidase studies in prosaposin- and sialidase-deficient fibroblast lines.
    Paton BC; Schneider-Jakob HR; Kopitz J; Harzer K; Poulos A; Cantz M
    Biol Chem Hoppe Seyler; 1994 Jan; 375(1):25-9. PubMed ID: 8003252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
    J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
    Rafi MA; Amini S; Zhang XL; Wenger DA
    Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
    Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
    Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
    J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.
    Paton BC; Hughes JL; Harzer K; Poulos A
    Eur J Cell Biol; 1990 Feb; 51(1):157-64. PubMed ID: 2109697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
    Inui K; Wenger DA
    Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
    Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
    Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.
    Harzer K; Paton BC; Poulos A; Kustermann-Kuhn B; Roggendorf W; Grisar T; Popp M
    Eur J Pediatr; 1989 Oct; 149(1):31-9. PubMed ID: 2514102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The precursor of sulfatide activator protein is processed to three different proteins.
    Fürst W; Machleidt W; Sandhoff K
    Biol Chem Hoppe Seyler; 1988 May; 369(5):317-28. PubMed ID: 3048308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of sphingolipid activator proteins].
    Suzuki Y
    Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.
    Fujita N; Suzuki K; Vanier MT; Popko B; Maeda N; Klein A; Henseler M; Sandhoff K; Nakayasu H; Suzuki K
    Hum Mol Genet; 1996 Jun; 5(6):711-25. PubMed ID: 8776585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.
    Rafi MA; de Gala G; Zhang XL; Wenger DA
    Somat Cell Mol Genet; 1993 Jan; 19(1):1-7. PubMed ID: 8460394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
    Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
    J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.